Turkish Validity And Reliability Of The Hammersmith Infant Neurological Evaluation (Hine)
NCT ID: NCT04259177
Last Updated: 2021-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
35 participants
OBSERVATIONAL
2020-03-15
2021-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Turkish Version of the Hammersmith Neonatal Neurological Examination (HNNE)
NCT07182513
Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
NCT05217186
The Prechtl's General Movement Assessment, Hammersmith Infant Neurological Examination and Sensory Profile-2
NCT05217199
Associations Between General Movements Assessments and Cognitive Development
NCT05217056
Development of a Scale for Evaluation of Neuromotor Development of Infants
NCT05860166
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scale
This test is divided into 3 sections: neurological examination, developmental motor boundary stones and behavioral status, and consists of a total of 37 items. The first part consists of 26 items such as cranial nerve functions, posture, quality, amount of movements, muscle tone, reflex and reactions. The second part evaluates motor development boundary stones consisting of 8 items. The third part refers to the behavioral condition consisting of 3 items. These items can be easily scored. It can be rated as optimal or inadequate. Each item is scored separately (as 0, 1, 2, 3) and the final total score is calculated. The total score ranges from 0-78. The total score shows the global optimal scores.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic lung disease, respiratory lung disease (RDS), broncho pulmonary dysplasia and babies with long-term o₂ support
* Gram negative bacterial sepsis, necrotizing enterocolitis (NEC), infantile apnea, preterm babies with cerebral malformation
* Low Apgar score (3 and below), Preterm babies with intrauterine growth retardation, multiple births (twins, triplets), Premature Retinopathy (ROP)
* Infants with prolonged severe hypoglycaemia and hypocalcemia
* Surgical conditions such as diaphragmatic hernia or tracheoesophageal fistula
* Infants who are small for gestational age (small for gestational age, sga, less than 3rd percentile) or large for gestational age (large for gestational age, LGA, greater than 97th percentile)
* Infants who received mechanical ventilation for more than 24 hours
* Infants younger than 32 gestational weeks and under 1500 kilograms
Exclusion Criteria
* Infants diagnosed with metabolic and genetic diseases (down syndrome, spinal muscular atrophy, duchenne muscular dystrophy..vs)
* Postterm Infants still dependent on intubation and mechanical ventilator at 3 months.
3 Months
12 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanko University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hatice Adıgüzel
Msc PhD. cd. Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hatice adıgüzel, PhD cd.
Role: PRINCIPAL_INVESTIGATOR
sanko Üniversitesi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sanko University
Gaziantep, Şehitkamil, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SankoUnv
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.